AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Pfizer announces third-quarter 2025 dividend of $0.43 per share, maintaining regular payout.
ByAinvest
Wednesday, Jun 25, 2025 5:33 pm ET1min read
Pfizer announces third-quarter 2025 dividend of $0.43 per share, maintaining regular payout.
New York, June 19, 2025 — Pfizer Inc. (NYSE: PFE) has declared a third-quarter 2025 cash dividend of $0.43 per share, payable on September 2, 2025. This dividend will be distributed to shareholders of record at the close of business on July 25, 2025. The announcement marks the 347th consecutive quarterly dividend paid by the pharmaceutical giant [1].Pfizer's dividend history is a testament to the company's financial stability and commitment to shareholder value. The latest dividend follows a consistent pattern of quarterly payouts, reflecting the company's robust financial performance and strong cash flow generation.
The dividend declaration comes amidst a period of significant innovation and growth for Pfizer. The company continues to focus on developing life-changing therapies and vaccines, with a global presence that spans both developed and emerging markets. Pfizer's dedication to improving patient outcomes and expanding access to reliable, affordable healthcare underscores its longstanding commitment to public health.
For more information about Pfizer's financial performance and upcoming events, investors are encouraged to visit the company's official website at www.Pfizer.com. For media inquiries, please contact PfizerMediaRelations@Pfizer.com or +1 (212) 733-1226. For investor relations, contact IR@Pfizer.com or +1 (212) 733-4848.
References:
[1] https://www.stocktitan.net/news/PFE/pfizer-declares-third-quarter-2025-epf5vw79qj01.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet